HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): David A. Simansky Alon Yellin Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Refaely, Y. Articles by Yellin, A. Search for Related Content PubMed PubMed Citation Articles by Refaely, Y. Articles by Yellin, A. Related Collections Mediastinum

Ann Thorac Surg 2001;72:366-370
© 2001 The Society of Thoracic Surgeons

---

Original article: general thoracic

Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread

^a Departments of Thoracic Surgery and Oncology, Sheba Medical Center, Tel Hashomer, Israel
^b Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Address reprint requests to Dr Yellin, Department of Thoracic Surgery, Sheba Medical Center, Tel Hashomer, Israel 52621
e-mail: ayellin{at}sheba.health.gov.il

Presented at the Poster Session of the Thirty-seventh Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 29–31, 2001.

Background. Thymoma and thymic carcinoma with pleural spread have a high rate of locoregional recurrence and poor prognosis. Maximal debulking coupled with aggressive local treatment could offer a chance for cure. This study evaluates the early and midterm results of operation and hyperthermic pleural perfusion with cisplatinum for thymic malignancies.

Methods. Fifteen patients (11 men), 20 to 67 years old (10 thymoma, 4 thymic carcinoma, 1 carcinoma in thymic cyst) underwent resection and hyperthermic pleural perfusion between 1995 to 2000. All had pleural spread proven before or intraoperatively. Six of the thymoma cases were recurrent. Current operation included resection without pleurectomy (9 patients), resection with pleurectomy (5), and extrapleural pneumonectomy (1 patient) with intraoperative hyperthermic pleural perfusion in all. Intrapleural temperature reached 40.3°C to 43°C. The total dose of cisplatinum was 150 mg or more in 14 patients.

Results. Complete resection (R0) was achieved in 10 patients, subtotal (R1) in 3, and partial (R2) in 2. There was no operative mortality, no hemodynamic or respiratory disturbances during perfusion, and no hematologic, neurologic, or renal complications. Complications consisted of significant bleeding (2 patients), fever (2), and air leak (1 patient). Two patients with thymic carcinoma died after 27 and 34 months, and 1 is alive with no evidence of disease at 54 months. Two patients with thymoma died after 7 and 36 months. Eight are alive after 9 to 70 months. Four patients (all R0) are alive without local recurrence more than 60 months after operation and hyperthermic pleural perfusion.

Conclusions. Operation and thermochemotherpy is feasible and safe in patients with thymic tumors. This method seems to offer excellent local control for patients with stage IV-a thymic malignancies. Midterm results suggest that operation plus hyperthermic pleural perfusion may lengthen survival in stage IV-a thymoma.

This article has been cited by other articles:

				M. Lucchi, F. Basolo, and A. Mussi Surgical treatment of pleural recurrence from thymoma Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 707 - 711. [Abstract] [Full Text] [PDF]

				E. de Bree, S. van Ruth, C. E. Schotborgh, P. Baas, and F. A. N. Zoetmulder Limited Cardiotoxicity after Extensive Thoracic Surgery and Intraoperative Hyperthermic Intrathoracic Chemotherapy with Doxorubicin and Cisplatin Ann. Surg. Oncol., October 1, 2007; 14(10): 3019 - 3026. [Abstract] [Full Text] [PDF]

				A. A. Mangi, J. C. Wain, D. M. Donahue, H. C. Grillo, D. J. Mathisen, and C. D. Wright Adjuvant Radiation of Stage III Thymoma: Is It Necessary? Ann. Thorac. Surg., June 1, 2005; 79(6): 1834 - 1839. [Abstract] [Full Text] [PDF]

				K. Kameyama, C.-l. Huang, E. Hayashi, and H. Yokomise Extended posterolateral-subcostal thoracotomy for extrapleural pneumonectomy: a surgical approach for radical operation of pleural mesothelioma Interactive CardioVascular and Thoracic Surgery, March 1, 2004; 3(1): 201 - 203. [Abstract] [Full Text] [PDF]

				N. Shigemura, A. Akashi, T. Nakagiri, K. Hazama, M. Ohta, and H. Matsuda Pleural perfusion thermo-chemotherapy under VATS: a new less invasive modality for advanced lung cancer with pleural spread Ann. Thorac. Surg., March 1, 2004; 77(3): 1016 - 1021. [Abstract] [Full Text] [PDF]

				C. Schroder, S. Fisher, A. C. Pieck, A. Muller, U. Jaehde, H. Kirchner, A. Haverich, and P. Macchiarini Technique and results of hyperthermic (41{degrees}C) isolated lung perfusion with high-doses of cisplatin for the treatment of surgically relapsing or unresectable lung sarcoma metastasis Eur. J. Cardiothorac. Surg., July 1, 2002; 22(1): 41 - 46. [Abstract] [Full Text] [PDF]

				R. A Vertrees, A. Leeth, M. Girouard, J. D Roach, and J. B Zwischenberger Whole-body hyperthermia: a review of theory, design and application Perfusion, July 1, 2002; 17(4): 279 - 290. [Abstract] [PDF]